JACQUELINE OWEN: Open Payments
NPI 1215171608 · LUMBERTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,917 in 80 payments from 19 companies in 2025. Trend: 2023 $625 · 2024 $1,508 · 2025 $1,917
Food & beverage: $1,917
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $276 |
| Teva Pharmaceuticals USA, Inc. | 10 | $188 |
| Braeburn Inc. | 3 | $182 |
| Vanda Pharmaceuticals Inc. | 4 | $162 |
| E.R. Squibb & Sons, L.L.C. | 3 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $147 |
| Axsome Therapeutics, Inc. | 8 | $142 |
| Lundbeck LLC | 9 | $136 |
| Janssen Pharmaceuticals, Inc | 6 | $130 |
| Alkermes, Inc. | 5 | $93 |
Products named: REXULTI, BRIXADI, COBENFY, CAPLYTA, Auvelity, FANAPT, UZEDY, ABILIFY ASIMTUFII.
Industry payments across NC — which companies pay providers there.
